Behind the Money

Behind the Money

Financial Times

PLAY PODCAST

Episode (200)

Halaman 3 dari 20

21
Whistleblowing in the UK, Ep. 1: The cost of speaking up

Whistleblowing in the UK, Ep. 1: The cost of speaking up

Dec 08, 2025

For years, corporate whistleblowers in the UK have found themselves in an unenviable predicament. They’re encouraged to report wrongdoing, but at the same time they often feel like they’ve risked ever...

22
Coming soon: The cost of corporate whistleblowing in the UK

Coming soon: The cost of corporate whistleblowing in the UK

Dec 05, 2025

For years, corporate whistleblowers in the UK have found themselves in an unenviable predicament. They’re encouraged to report wrongdoing, but at the same time they often feel like they’ve risked thei...

23
Business History: The Secret of Southwest’s Success

Business History: The Secret of Southwest’s Success

Dec 03, 2025

This week we’re sharing an episode from Business History, a podcast from Pushkin Industries. Former Planet Money hosts Jacob Goldstein and Robert Smith explore what the businesses of the past can teac...

24
KKR, Bain and private equity’s push into Japan

KKR, Bain and private equity’s push into Japan

Nov 26, 2025

When international private equity groups first entered Japan at the turn of the 21st century, newspapers criticised them as vulture funds and politicians steered clear of public contact. Today, it’s a...

25
Coming soon from Tech Tonic: Defying death

Coming soon from Tech Tonic: Defying death

Nov 24, 2025

Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing...

26
What’s the deal with OpenAI's deals?

What’s the deal with OpenAI's deals?

Nov 19, 2025

OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But thos...

27
Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Nov 12, 2025

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multib...

28
The $17bn nuclear start-up without any revenue

The $17bn nuclear start-up without any revenue

Nov 05, 2025

Publicly-listed Oklo sits at the intersection of two hot areas for Wall Street: artificial intelligence and energy companies. This year alone, Oklo’s share price has jumped more than 400 per cent. But...

29
$12bn of debt: How First Brands Group collapsed

$12bn of debt: How First Brands Group collapsed

Oct 29, 2025

Some of the world’s biggest financial institutions are reeling after the collapse of a little-known car parts supplier: First Brands Group. The company filed for bankruptcy last month, and since then,...

30
Can the world’s largest listed hedge fund rebound?

Can the world’s largest listed hedge fund rebound?

Oct 22, 2025

The world’s largest listed hedge fund manager, Man Group, is at a crossroads. After years of high flying thanks to its innovative quant trading strategies, the company’s hedge fund unit has been falte...

Menampilkan 21 - 30 dari 200 episode